ViaDerma, Inc. Files Amended Financial Statements
August 24, 2021 10:23 ET
|
ViaDerma, Inc.
LOS ANGELES, Aug. 24, 2021 (GLOBE NEWSWIRE) -- ViaDerma, Inc., (“Company”) (OTC Pink: VDRM) published a Quarterly Report for the three months ended March 31, 2021, on the OTC Markets website...
ViaDerma, Inc. Provides Updates on Current Business Activities
June 24, 2021 05:00 ET
|
ViaDerma, Inc.
LOS ANGELES, June 24, 2021 (GLOBE NEWSWIRE) -- ViaDerma, Inc., (“Company”) (OTC Pink: VDRM), is pleased to provide an update on current business activities. The Company has finalized a ten-year $12...
ViaDerma, Inc. Announces Expansion of its Current Licensing Agreement and Provides Additional Company Updates
June 02, 2021 05:00 ET
|
ViaDerma, Inc.
LOS ANGELES, June 02, 2021 (GLOBE NEWSWIRE) -- ViaDerma, Inc., (“Company”) (OTC Pink: VDRM), is pleased to announce they have expanded their current licensing agreement with a home health wound care...
ViaDerma, Inc. Nearing Initial Order from Large Hospital Network
May 13, 2021 05:00 ET
|
ViaDerma, Inc.
LOS ANGELES, May 13, 2021 (GLOBE NEWSWIRE) -- ViaDerma, Inc., (“Company”) (OTC Pink: VDRM), announced they are nearing the end of their discussions with a major healthcare network to finalize an...
ViaDerma, Inc. Provides Preliminary Revenue Estimates and Highlights for its Record Breaking 1st Quarter
April 08, 2021 05:00 ET
|
ViaDerma, Inc.
LOS ANGELES, April 08, 2021 (GLOBE NEWSWIRE) -- ViaDerma, Inc., (“Company”) (OTC Pink: VDRM), is pleased to provide an update of estimated sales and revenue numbers for the first quarter of 2021, as...
ViaDerma, Inc. Announces the Payment of all Toxic Convertible Notes and Has Become Debt Free
March 16, 2021 05:00 ET
|
ViaDerma, Inc.
LOS ANGELES, March 16, 2021 (GLOBE NEWSWIRE) -- ViaDerma, Inc., (“Company”) (OTC Pink: VDRM), is pleased to announce they have paid off all outstanding toxic convertible debt and the Company is now...
ViaDerma, Inc. Completes a Licensing Agreement with a Group of Affiliate Wound Care Medical Practices Operating in Six States
January 21, 2021 05:00 ET
|
ViaDerma, Inc.
LOS ANGELES, Jan. 21, 2021 (GLOBE NEWSWIRE) -- ViaDerma, Inc., (“Company”) (OTC Pink: VDRM), announces the completion of a licensing agreement with a group of affiliated wound care medical...
ViaDerma Inc., Provides Review of 2020 and Looks Forward to 2021
January 13, 2021 05:00 ET
|
ViaDerma, Inc.
LOS ANGELES, Jan. 13, 2021 (GLOBE NEWSWIRE) -- ViaDerma, Inc., (“Company”) (OTC Pink:VDRM), President and CEO, Dr. Christopher Otiko offers a review of 2020 and provides a summary of his...
ViaDerma, Inc. Provides an Update on its Current Marketing Efforts
August 27, 2020 05:00 ET
|
ViaDerma, Inc.
LOS ANGELES, Aug. 27, 2020 (GLOBE NEWSWIRE) -- ViaDerma, Inc., (“Company”) (OTC Pink:VDRM), is pleased to provide this update on its current marketing efforts and ongoing product trials of its...
ViaDerma, Inc. Provides a Corporate Update
June 23, 2020 05:00 ET
|
ViaDerma, Inc.
LOS ANGELES, June 23, 2020 (GLOBE NEWSWIRE) -- ViaDerma, Inc., (“Company”) (OTC Pink:VDRM), is pleased to provide this corporate update: ViaDerma has partnered with the Brewer Group, Inc., to...